The potential rescheduling of cannabis on the Controlled Substances Act (CSA) has already felt like quite the saga. In October 2022, President Joe Biden requested that...
The DEA has rescinded a 2023 directive which previously ordered a pharmaceutical company to shutter operations after they were found to have helped perpetuate the nationwide...
The Department of Justice has rescinded a DEA decision to fire a special agent who was let go due to a positive reading for CBD on a drug...
The U.S. Drug Enforcement Administration (DEA) has made its position on psilocybin and psilocin, two psychedelic compounds produced by “magic” mushrooms, fairly clear as states across...
The Drug Enforcement Agency (DEA) posted a notice on the Federal Register on Jan. 3, which includes the most recent breakdown of Schedule I Substances in its 2024...
Federal law enforcement agents sent a warning letter dated Nov. 27 to pharmacies across Georgia, warning them that dispensing and selling cannabis oil is illegal under...
As we continue to witness the massive modern shift surrounding drugs—including cannabis and a number of other psychoactive substances—it appears that the powers that be are...
The Drug Enforcement Administration (DEA) recently released its National Forensic Laboratory Information System (NFLIS) Drug 2022 Annual Report, which compiles drug testing data collected during 2022. The...
A group of Republican legislators recently sent a letter to the Drug Enforcement Administration (DEA) asking for the agency to reject the recent recommendation to reschedule...
The Drug Enforcement Administration recently defended their decision to fire an “outstanding” special agent fired earlier this year for using CBD oil to replace his pain...